Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anna Raszeja-Specht"'
Autor:
Anna Raszeja-Specht, Anna Michno
Publikováno v:
Diagnostyka Laboratoryjna. 51:221-228
A new generation of oral anticoagulants, direct thrombin or activated factor X inhibitors gradually replaces the existing antithrombotic agents, administered parenterally (heparin) or orally (vitamin K antagonists). Currently, the most widely used cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03e297b02ab62ec945233fc5bf17f22e
https://doi.org/10.5604/01.3001.0008.2262
https://doi.org/10.5604/01.3001.0008.2262
Autor:
Anna Raszeja-Specht, Agnieszka Jankowska-Kulawy, Andrzej Szutowicz, Anna Michno, Tadeusz Pawelczyk
Publikováno v:
Clinical Chemistry. 51:1673-1682
Background: Excessive blood platelet activity contributes to vascular complications in diabetic persons. Increased acetyl-CoA in platelets from diabetic persons has been suggested to be a cause of this hyperactivity. We therefore investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba19c2c56bef7e23a76b95f2ddca729
https://doi.org/10.1373/clinchem.2005.050328
https://doi.org/10.1373/clinchem.2005.050328
Publikováno v:
American Journal of Hematology. 68:32-36
Three subgroups have been distinguished in essential thrombocythaemia (ET) patients, on the basis of clinical and laboratory findings. ET patients with bleeding incidents had smaller platelet volume, lower concentrations of b-thromboglobulin and plat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b31cfb51be1df792ff5578e55b5f9a
https://doi.org/10.1002/ajh.1145
https://doi.org/10.1002/ajh.1145
Publikováno v:
Metabolism: clinical and experimental. 53(1)
Diabetes is known to increase blood platelet activity. Activities of pyruvate dehydrogenase (PDH), adenosine triphosphate (ATP)-citrate lyase (ATPCL), acetyl-coenzyme A (acetyl-CoA) content, malonyl dialdehyde (MDA), synthesis, and platelet aggregati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c9bdf22937fb7fdb2550c622e9786c
https://pubmed.ncbi.nlm.nih.gov/14681844
https://pubmed.ncbi.nlm.nih.gov/14681844
Publikováno v:
Clinical chemistry and laboratory medicine. 41(9)
Blood platelets take up glucose through insulin-independent GLUT-3 transporter. It is, however, unclear how diabetes affects further steps of glucose and glucose-derived acetyl-coenzyme A (CoA) metabolism in platelets. There is no evidence to explain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cacb5a60facf5d0a483c195b1488ed4
https://pubmed.ncbi.nlm.nih.gov/14598862
https://pubmed.ncbi.nlm.nih.gov/14598862
Publikováno v:
Journal of Biological Chemistry. 263:18419-18429
Eight monoclonal antibodies are described which are directed against the renal Na+-D-glucose cotransporter. In porcine renal brush-border membranes, the antibodies either bind to one or to three polypeptides which have been identified as components o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd143eda6a69ac0d46ea81f96aec92e
https://doi.org/10.1016/s0021-9258(19)81375-3
https://doi.org/10.1016/s0021-9258(19)81375-3
Publikováno v:
Biochimica et biophysica acta. 985(2)
Monoclonal antibodies which interact with the mammalian Na+/ d -glucose cotransporter and bind to Mr 75 000 and Mr 47 000 polypeptide components of this transporter have been described (Koepsell, H., Korn, K., Raszeja-Specht, A., Bernotat-Danielowski
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239760508bd0841112a0a6c58a9582ac
https://pubmed.ncbi.nlm.nih.gov/2804100
https://pubmed.ncbi.nlm.nih.gov/2804100